Thu, Jul 24, 2014, 4:35 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Arrowhead Research Corp. Message Board

  • wiggum12001 wiggum12001 Jan 25, 2013 11:26 AM Flag

    It's over

    It's all over except for the crying here. Two offerings in 45 days at ridiculous terms, this is a joke.

    These warrants are nothing more than a giveaway to bring down the effective offering price without having to price the deal 30% below the market.

    In the last five months alone they have now done 3 offerings for gross proceeds of $14M for 5.8M shares and 3.5M warrants. The net effective price of these offerings was $1.51 (you could make argument I shouldn't include warrants from the August 2012 offering, as at least their exercise price was ~20% above the offering price, but the last two offerings were pure giveaways).

    On just a basic sharecount basis, ARWR now has 17M shares outstanding, which is up from 10.5M at time of R/S and 3 years

    They have yet to sign a single partnership that had any material upfront cash component to it

    They purchased from Roche assets with some potentially interesting technology and a research facility for literally pennies on the dollar for what Roche had paid for it only a few years earlier.

    Can someone please explain to me why we should expect the next five years to look any differently than the previous five? And please no spouting this nonsense about short-term focus, etc. You may be new to the company but these are the facts of the past five years before you came upon this company.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ARWR
11.44-0.22(-1.89%)4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.